Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An intrahepatic cholangiocarcinoma that arises from the canals of Hering.
Biomarker and diagnostic research for cholangiolocellular carcinoma has been reported in the published literature.
No clinical trials have been registered for cholangiolocellular carcinoma.
7 publications have been identified in PubMed for cholangiolocellular carcinoma. Research spans Case Report / Case Series (57%), Diagnostic / Biomarker (14%), and Basic Science / Preclinical (14%).
Kubota N (2026). [PMID: 41770625](https://pubmed.ncbi.nlm.nih.gov/41770625/). *Cancer Sci*. [Diagnostic / Biomarker]
Tsukamoto T (2025). [PMID: 41546366](https://pubmed.ncbi.nlm.nih.gov/41546366/). *Gan To Kagaku Ryoho*. [Case Report / Case Series]
Katsura Y (2025). [PMID: 39957223](https://pubmed.ncbi.nlm.nih.gov/39957223/). *Gan To Kagaku Ryoho*. [Case Report / Case Series]
Sasaki M (2025). [PMID: 40349569](https://pubmed.ncbi.nlm.nih.gov/40349569/). *Pathol Res Pract*. [Basic Science / Preclinical]
Matsubara K (2024). [PMID: 39348996](https://pubmed.ncbi.nlm.nih.gov/39348996/). *Anticancer Res*. [Epidemiology / Natural History]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 10:04 AM UTC
Shao W (2024). [PMID: 39650917](https://pubmed.ncbi.nlm.nih.gov/39650917/). *Cureus*. [Case Report / Case Series]